Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK− ALCL
Emma Andersson, Oscar Brück, Till Braun, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 702-702
Open Access | Times Cited: 23

Showing 23 citing articles:

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Cosimo Lobello, Boris Tichý, Vojtěch Bystrý, et al.
Leukemia (2020) Vol. 35, Iss. 5, pp. 1500-1505
Open Access | Times Cited: 42
JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology
Megan J. Fitzpatrick, Lucas R. Massoth, Chelsea Marcus, et al.
The American Journal of Surgical Pathology (2021) Vol. 45, Iss. 7, pp. 895-904
Closed Access | Times Cited: 37
Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies
Yurou Xing, Junmeng Huang, Yi Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
Daehong Kim, Giljun Park, Jani Huuhtanen, et al.
Leukemia (2021) Vol. 35, Iss. 12, pp. 3430-3443
Open Access | Times Cited: 28
Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins
Clifford Liongue, Alister C. Ward
Cancers (2024) Vol. 16, Iss. 2, pp. 313-313
Open Access | Times Cited: 3
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Caiqin Xie, Xian Li, Hui Zeng, et al.
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Peripheral T‐cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK‐negative
Karthik A. Ganapathi, Alina Nicolae, Caoimhe Egan, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1862-1871
Open Access | Times Cited: 2
Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine
Lina Hu, Xuanye Zhang, Shengbing Zang
Cancer Biology and Medicine (2024), pp. 1-15
Open Access | Times Cited: 2
Carbazole Derivatives as STAT Inhibitors: An Overview
Anna Caruso, Alexia Barbarossa, Alessia Carocci, et al.
Applied Sciences (2021) Vol. 11, Iss. 13, pp. 6192-6192
Open Access | Times Cited: 17
PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas
Wei Xie, L. Jeffrey Medeiros, Shaoying Li, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1587-1587
Open Access | Times Cited: 11
Genetic alterations and oxidative stress in T cell lymphomas
Sushant Kumar, Bhavuk Dhamija, Diksha Attrish, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108109-108109
Closed Access | Times Cited: 8
Targeting STAT3 and STAT5 in Cancer
Elvin D. de Araujo, György M. Keserü, Patrick T. Gunning, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2002-2002
Open Access | Times Cited: 12
INSM1 promotes breast carcinogenesis by regulating C-MYC.
Yinan Guan, Yulu Sun, Zheying Liu, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3500-3516
Closed Access | Times Cited: 4
Angioimmunoblastic T-cell Lymphoma: Current Diagnostic Insights and Advances.
Nana Matsumoto, Mina L. Xu
Human Pathology (2024), pp. 105696-105696
Open Access | Times Cited: 1
How molecular advances may improve the diagnosis and management of PTCL patients
Fanny Drieux, François Lemonnier, Philippe Gaulard
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK− Anaplastic Large Cell Lymphomas
Jianchao Wang, Lihua Zhong, Wei-qing Lin, et al.
The American Journal of Surgical Pathology (2022) Vol. 47, Iss. 1, pp. 55-64
Closed Access | Times Cited: 5
How to Sequence Therapies in Peripheral T Cell Lymphoma
Kitsada Wudhikarn, N. Nora Bennani
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 9
Closed Access | Times Cited: 7
Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK- ALCL vs. CD30high PTCL, NOS
Chenxi Xiang, Wanna Wu, Meiting Fan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Maintenance Therapy Post-Stem Cell Transplantation for Patients with T-Cell Lymphomas
Zachary Braunstein, Jonathan E. Brammer
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 6, pp. 276-284
Open Access
Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS)
Lifen Zhu, Shufang Xie, Yang Chen, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 5275-5286
Open Access | Times Cited: 3
Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas
Jean‐Philippe Merlio, Marshall E. Kadin
Cancers (2021) Vol. 13, Iss. 17, pp. 4256-4256
Open Access | Times Cited: 1
The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas
Victor Tomacinschii, Adrián Mosquera Orgueira, Carlos Aliste Santos, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
Page 1

Scroll to top